Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Completed · Phase 3

Conditions studied: Pancreatic Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if gemcitabine is more effective with or without exatecan mesylate in treating pancreatic cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of gemcitabine alone to that of gemcitabine and exatecan mesylate in treating patients who have locally advanced or metastatic pancreatic cancer.

Key facts

Study ID

NCT00023972

Run by

Daiichi Sankyo

Starts

2001-07-01

Expected to finish

2005-04-01

Last updated by the study team

2012-05-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Providence Cancer Center — Mobile, Alabama, United States
• Arizona Clinical Research Center — Tucson, Arizona, United States
• Medical Oncology/Hematology — Gilroy, California, United States
• California Cancer Care, Inc. — Greenbrae, California, United States
• Pacific Shores Medical Group — Long Beach, California, United States
• Cancer and Blood Institute of the Desert — Rancho Mirage, California, United States
• Sutter Cancer Center — Sacramento, California, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Medical Oncology and Hematology, P.C. — Hamden, Connecticut, United States
• nTouch Research — Melbourne, Florida, United States
• Sylvester Cancer Center, University of Miami — Miami, Florida, United States
• MD Anderson Cancer Center Orlando — Orlando, Florida, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Peachtree Hematology and Oncology Consultants, P.C. — Atlanta, Georgia, United States
• Emory University School of Medicine — Atlanta, Georgia, United States
• Central Georgia Hematology Oncology, P.C. — Macon, Georgia, United States
• Cancer Research Center of Hawaii — Honolulu, Hawaii, United States
• Northwestern Memorial Hospital — Chicago, Illinois, United States
• Lutheran General Cancer Care Center — Park Ridge, Illinois, United States
• Hope Center — Terre Haute, Indiana, United States
• Harbor Hospital Center — Baltimore, Maryland, United States
• Oncology-Hematology Associates, P.A. — Clinton, Maryland, United States
• Providence Hospital Cancer Center — Southfield, Michigan, United States
• Virginia Piper Cancer Institute — Minneapolis, Minnesota, United States
• Intouch Research — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.